Home Cart 0 Sign in  

[ CAS No. 1201326-81-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 1201326-81-9
Chemical Structure| 1201326-81-9
Structure of 1201326-81-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 1201326-81-9 ]

Related Doc. of [ 1201326-81-9 ]

Alternatived Products of [ 1201326-81-9 ]

Product Details of [ 1201326-81-9 ]

CAS No. :1201326-81-9 MDL No. :MFCD16495880
Formula : C8H9NO4S Boiling Point : -
Linear Structure Formula :- InChI Key :OANIRYJPNCZNHW-UHFFFAOYSA-N
M.W : 215.23 Pubchem ID :53429647
Synonyms :

Calculated chemistry of [ 1201326-81-9 ]

Physicochemical Properties

Num. heavy atoms : 14
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.25
Num. rotatable bonds : 3
Num. H-bond acceptors : 5.0
Num. H-bond donors : 0.0
Molar Refractivity : 48.61
TPSA : 81.71 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.41 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.21
Log Po/w (XLOGP3) : 0.28
Log Po/w (WLOGP) : 1.35
Log Po/w (MLOGP) : -0.11
Log Po/w (SILICOS-IT) : 0.53
Consensus Log Po/w : 0.65

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.47
Solubility : 7.29 mg/ml ; 0.0339 mol/l
Class : Very soluble
Log S (Ali) : -1.56
Solubility : 5.96 mg/ml ; 0.0277 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.42
Solubility : 0.816 mg/ml ; 0.00379 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.12

Safety of [ 1201326-81-9 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 1201326-81-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 1201326-81-9 ]
  • Downstream synthetic route of [ 1201326-81-9 ]

[ 1201326-81-9 ] Synthesis Path-Upstream   1~5

  • 1
  • [ 67-56-1 ]
  • [ 1201326-81-9 ]
YieldReaction ConditionsOperation in experiment
65%
Stage #1: With 3-chloro-benzenecarboperoxoic acid In tetrahydrofuran at 20℃; for 0.25 h; Molecular sieve
Stage #2: at 20℃; for 0.25 h; Molecular sieve
General procedure: The reaction vessel was charged with the heteroaromatic malononitrile (1.0 equiv,prepared according to ref. 6) and the specified solvent (1 mL per0.12 mmol). It was stirred at r.t. and 4 Å molecular sieve was added. Anhydrous m-CPBA (1.5 equiv) solution was prepared by dissolving in the specified solvent (1 mL per 0.22 mmol) and drying over molecular sieves (4 Å) for 10 min. This solution was added to the reaction mixture which was subsequently stirred for 10 min. After adding the nucleophile, the reaction mixture was stirred at r.t. The reaction was finally quenched with aq sodium thiosulfate solution and extracted with CH2Cl2. The combined organics were washed twice with saturated aqueous solution of NaHCO3 and brine, dried over Na2SO4 and concentrated in vacuo. Further purification was carried out by preparative HPLC.
Reference: [1] Synlett, 2015, vol. 26, # 10, p. 1365 - 1370
  • 2
  • [ 30766-11-1 ]
  • [ 1201326-81-9 ]
Reference: [1] Patent: WO2012/76898, 2012, A1,
[2] Journal of Medicinal Chemistry, 2013, vol. 56, # 7, p. 3012 - 3023
  • 3
  • [ 29682-15-3 ]
  • [ 1201326-81-9 ]
Reference: [1] Patent: WO2012/76898, 2012, A1,
[2] Journal of Medicinal Chemistry, 2013, vol. 56, # 7, p. 3012 - 3023
  • 4
  • [ 1201326-81-9 ]
  • [ 95-51-2 ]
  • [ 1380672-71-8 ]
YieldReaction ConditionsOperation in experiment
87.2%
Stage #1: With trimethylaluminum In toluene at 80 - 90℃; for 2 h;
Stage #2: With hydrogenchloride In water; toluene
(d) Preparation of N-(2-chlorophenyl)-5-(methylsulfonyl)picolinamide 5:2-Chloroaniline (1.20 g, 0.0093 mol) in toluene (20 mL) was added to trimethylaluminum (2.0 M 4.6 mL) then methyl 5-(methylsulfonyl)picolinate 4 (1.0 g, 4.65 mol) was added and the mixture was heated to 80-90°C for 2 h. The reaction mixture was cooled down and IN HC1 solution (10 mL) was added to be acidic. Dichloromethane (100 mL) was then added and the organic phase was further washed with water (100 mL) and dried over sodium sulfate. The solvent was removed and the residue was mixed with ether (50 mL) and stirred for 0.5 h. The solid was filtered and dried to give N-(2-chlorophenyl)-5-(methylsulfonyl)picolinamide 5 as a light yellow solid. Yield: 1.26 g, 87.2percent. 1H-NMR (300 Hz, CDCI3) δ (ppm): 10.6 (s, 1H), 9.21 (m, 1H), 8.62 (dd, 1H), 8.51 (dd, 1H), 8.46 (dd, 1H), 7.45 (dd, 1H),7.34 (td, 1H), 7.12 (td, 1H),3.20 (s, 3H).
Reference: [1] Patent: WO2012/76898, 2012, A1, . Location in patent: Page/Page column 65-66
[2] Journal of Medicinal Chemistry, 2013, vol. 56, # 7, p. 3012 - 3023
  • 5
  • [ 1201326-81-9 ]
  • [ 1380672-07-0 ]
Reference: [1] Patent: WO2012/76898, 2012, A1,
[2] Journal of Medicinal Chemistry, 2013, vol. 56, # 7, p. 3012 - 3023
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 1201326-81-9 ]

Esters

Chemical Structure| 918967-32-5

[ 918967-32-5 ]

Ethyl 5-(Methylsulfonyl)pyridine-2-carboxylate

Similarity: 0.97

Chemical Structure| 1256633-19-8

[ 1256633-19-8 ]

Ethyl 3-(methylsulfonyl)picolinate

Similarity: 0.91

Chemical Structure| 1314406-40-0

[ 1314406-40-0 ]

Ethyl 5-(Ethylsulfonyl)pyridine-2-carboxylate

Similarity: 0.90

Chemical Structure| 205873-28-5

[ 205873-28-5 ]

Methyl 5-(methylsulfonyl)-1H-indole-2-carboxylate

Similarity: 0.85

Chemical Structure| 220679-12-9

[ 220679-12-9 ]

Ethyl 5-(methylsulfonyl)-1H-indole-2-carboxylate

Similarity: 0.83

Sulfones

Chemical Structure| 1186663-48-8

[ 1186663-48-8 ]

5-(Methylsulfonyl)picolinic acid

Similarity: 0.94

Chemical Structure| 918967-32-5

[ 918967-32-5 ]

Ethyl 5-(Methylsulfonyl)pyridine-2-carboxylate

Similarity: 0.97

Chemical Structure| 1186663-48-8

[ 1186663-48-8 ]

5-(Methylsulfonyl)picolinic acid

Similarity: 0.92

Chemical Structure| 1256633-19-8

[ 1256633-19-8 ]

Ethyl 3-(methylsulfonyl)picolinate

Similarity: 0.91

Chemical Structure| 1314406-40-0

[ 1314406-40-0 ]

Ethyl 5-(Ethylsulfonyl)pyridine-2-carboxylate

Similarity: 0.90

Related Parent Nucleus of
[ 1201326-81-9 ]

Pyridines

Chemical Structure| 1186663-48-8

[ 1186663-48-8 ]

5-(Methylsulfonyl)picolinic acid

Similarity: 0.94

Chemical Structure| 918967-32-5

[ 918967-32-5 ]

Ethyl 5-(Methylsulfonyl)pyridine-2-carboxylate

Similarity: 0.97

Chemical Structure| 1186663-48-8

[ 1186663-48-8 ]

5-(Methylsulfonyl)picolinic acid

Similarity: 0.92

Chemical Structure| 1256633-19-8

[ 1256633-19-8 ]

Ethyl 3-(methylsulfonyl)picolinate

Similarity: 0.91

Chemical Structure| 1314406-40-0

[ 1314406-40-0 ]

Ethyl 5-(Ethylsulfonyl)pyridine-2-carboxylate

Similarity: 0.90